Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.014 EUR | 0.00% | 0.00% | +2,700.00% |
Valuation
Fiscal Period: August | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 7.695 | 7.013 | 11.22 | 9.433 | 7.21 | 3.593 |
Enterprise Value (EV) 1 | 6.857 | 6.832 | 9.853 | 3.462 | 5.324 | 3.071 |
P/E ratio | -7.49 x | -8.81 x | -35.4 x | 3.86 x | -2.13 x | -1.14 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -6.76 x | -9.18 x | -19.1 x | -2.88 x | -1.73 x | -1.3 x |
EV / FCF | -10.4 x | -28.6 x | -7.85 x | -6.75 x | -1.51 x | -6.1 x |
FCF Yield | -9.59% | -3.5% | -12.7% | -14.8% | -66.4% | -16.4% |
Price to Book | 1.17 x | 1.21 x | 2.05 x | 0.99 x | 3.04 x | 54.3 x |
Nbr of stocks (in thousands) | 139,906 | 140,256 | 140,256 | 157,217 | 160,217 | 179,658 |
Reference price 2 | 0.0550 | 0.0500 | 0.0800 | 0.0600 | 0.0450 | 0.0200 |
Announcement Date | 12/13/18 | 12/12/19 | 12/18/20 | 12/16/21 | 12/21/23 | 12/21/23 |
Income Statement Evolution (Annual data)
Fiscal Period: August | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -1.014 | -0.744 | -0.5158 | -1.201 | -3.079 | -2.364 |
EBIT 1 | -1.017 | -0.7468 | -0.5179 | -1.204 | -3.082 | -2.365 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -1.025 | -0.7958 | -0.3174 | 2.33 | -3.353 | -3.293 |
Net income 1 | -1.025 | -0.7958 | -0.3174 | 2.33 | -3.353 | -3.062 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.007342 | -0.005676 | -0.002262 | 0.0155 | -0.0211 | -0.0175 |
Free Cash Flow 1 | -0.6576 | -0.2392 | -1.255 | -0.5131 | -3.536 | -0.5033 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 12/13/18 | 12/12/19 | 12/18/20 | 12/16/21 | 12/21/23 | 12/21/23 |
Balance Sheet Analysis
Fiscal Period: August | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 0.84 | 0.18 | 1.37 | 5.97 | 1.89 | 0.52 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -0.66 | -0.24 | -1.26 | -0.51 | -3.54 | -0.5 |
ROE (net income / shareholders' equity) | -14.6% | -12.9% | -5.64% | 31.2% | -56.5% | -250% |
ROA (Net income/ Total Assets) | -8.89% | -7.24% | -5.22% | -8.75% | -27.7% | -81.6% |
Assets 1 | 11.53 | 10.99 | 6.077 | -26.62 | 12.11 | 3.753 |
Book Value Per Share 2 | 0.0500 | 0.0400 | 0.0400 | 0.0600 | 0.0100 | 0 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Capex 1 | 0.29 | 0.03 | 0.55 | 1.34 | 0 | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 12/13/18 | 12/12/19 | 12/18/20 | 12/16/21 | 12/21/23 | 12/21/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-14.76% | 143B | |
-6.37% | 117B | |
+0.06% | 71.07B | |
+5.25% | 50.28B | |
+13.30% | 48.38B | |
+36.13% | 39.93B | |
+22.92% | 26.1B | |
+33.36% | 21.36B | |
+58.44% | 18.64B |
- Stock Market
- Equities
- LOT Stock
- OTM Stock
- Financials TomaGold Corporation